$CLSD
Clearside Biomedical, Inc.

2019 Q1 Form 10-K Financial Statement

#000156459019007887 Filed on March 15, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $45.00K $30.00K $60.00K
YoY Change -91.3% 500.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.380M $14.68M $2.440M
YoY Change 42.67% 51.34% 2.09%
% of Gross Profit
Research & Development $10.97M $68.29M $13.94M
YoY Change -18.01% 39.22% 100.0%
% of Gross Profit
Depreciation & Amortization $53.00K $189.0K $40.00K
YoY Change 12.77% 3.85% 100.0%
% of Gross Profit
Operating Expenses $15.35M $82.98M $16.38M
YoY Change -6.7% 41.23% 74.92%
Operating Profit -$15.31M -$82.95M
YoY Change -6.97% 42.01%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$98.00K $127.0K -$170.0K
YoY Change -36.36% -122.4% -48.48%
Pretax Income -$15.40M -$82.82M -$16.49M
YoY Change -7.28% 40.42% 70.18%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.40M -$82.82M -$16.49M
YoY Change -7.24% 40.43% 70.28%
Net Earnings / Revenue -34231.11% -276060.0% -27488.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$451.1K -$2.695M -$650.5K
COMMON SHARES
Basic Shares Outstanding 36.04M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.90M $40.88M $37.64M
YoY Change -65.48% 8.61% -54.99%
Cash & Equivalents $32.95M $8.040M $9.224M
Short-Term Investments $2.000M $32.84M $28.42M
Other Short-Term Assets $500.0K $2.070M $116.0K
YoY Change -77.27% 31.85% -60.0%
Inventory
Prepaid Expenses $1.445M
Receivables
Other Receivables
Total Short-Term Assets $35.50M $42.94M $39.20M
YoY Change -65.6% 9.54% -53.51%
LONG-TERM ASSETS
Property, Plant & Equipment $1.700M $790.0K $885.0K
YoY Change 112.5% -11.24% 841.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $390.0K $47.00K
YoY Change 0.0% -4.88% 11.9%
Total Long-Term Assets $2.000M $1.180M $1.292M
YoY Change 53.85% -8.53% 160.48%
TOTAL ASSETS
Total Short-Term Assets $35.50M $42.94M $39.20M
Total Long-Term Assets $2.000M $1.180M $1.292M
Total Assets $37.50M $44.12M $40.49M
YoY Change -64.11% 8.97% -52.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.300M $6.870M $5.384M
YoY Change -20.9% 27.7% 107.56%
Accrued Expenses $5.000M $2.920M $4.716M
YoY Change 35.14% -38.14% 68.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M $560.0K $3.200M
YoY Change -56.25% -82.5%
Total Short-Term Liabilities $11.70M $10.48M $13.52M
YoY Change -15.22% -22.49% 149.98%
LONG-TERM LIABILITIES
Long-Term Debt $8.647M $9.420M $4.809M
YoY Change 110.9% 95.84% -36.61%
Other Long-Term Liabilities $1.100M $610.0K $800.0K
YoY Change 83.33% -18.67% 300.0%
Total Long-Term Liabilities $8.647M $10.03M $4.809M
YoY Change 83.98% 80.4% -36.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.70M $10.48M $13.52M
Total Long-Term Liabilities $8.647M $10.03M $4.809M
Total Liabilities $21.40M $20.50M $19.08M
YoY Change 15.68% 7.44% 45.04%
SHAREHOLDERS EQUITY
Retained Earnings -$124.2M
YoY Change 90.39%
Common Stock $25.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.09M $23.62M $21.42M
YoY Change
Total Liabilities & Shareholders Equity $37.50M $44.12M $40.49M
YoY Change -64.11% 8.97% -52.26%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$15.40M -$82.82M -$16.49M
YoY Change -7.24% 40.43% 70.28%
Depreciation, Depletion And Amortization $53.00K $189.0K $40.00K
YoY Change 12.77% 3.85% 100.0%
Cash From Operating Activities -$12.65M -$79.20M -$15.09M
YoY Change -19.17% 55.04% 133.59%
INVESTING ACTIVITIES
Capital Expenditures $18.00K $88.00K $0.00
YoY Change -71.24%
Acquisitions
YoY Change
Other Investing Activities $30.95M -$3.670M $7.960M
YoY Change 152.65% -117.96% -127.38%
Cash From Investing Activities $30.93M -$3.760M $7.960M
YoY Change 152.61% -118.69% -127.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $8.300M
YoY Change
Cash From Financing Activities 6.628M 81.78M 70.00K
YoY Change -91.61% 1425.16% -99.79%
NET CHANGE
Cash From Operating Activities -12.65M -79.20M -15.09M
Cash From Investing Activities 30.93M -3.760M 7.960M
Cash From Financing Activities 6.628M 81.78M 70.00K
Net Change In Cash 24.91M -1.181M -7.060M
YoY Change -67.06% -95.39% 244.39%
FREE CASH FLOW
Cash From Operating Activities -$12.65M -$79.20M -$15.09M
Capital Expenditures $18.00K $88.00K $0.00
Free Cash Flow -$12.67M -$79.29M -$15.09M
YoY Change -19.05% 54.29% 133.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36039245
CY2018Q2 dei Entity Public Float
EntityPublicFloat
298881000
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2017 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
212000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
283000
CY2016 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
108000
CY2016 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
33459000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
66000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
239000
CY2016 us-gaap Depreciation
Depreciation
65000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1314000
CY2016 us-gaap Profit Loss
ProfitLoss
-25882000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
43000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
487000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79200000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.33
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-58975000
CY2018 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
79564000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8043000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
4785000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
3364000
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
154000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9224000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
32835000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
28416000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2049000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1445000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
116000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
42944000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
39201000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
790000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
885000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
360000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
360000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47000
CY2018Q4 us-gaap Assets
Assets
44120000
CY2017Q4 us-gaap Assets
Assets
40493000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6869000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5384000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2923000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4716000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
556000
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
128000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
199000
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10476000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13519000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9419000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4809000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
605000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
610000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
140000
CY2018Q4 us-gaap Liabilities
Liabilities
20500000
CY2017Q4 us-gaap Liabilities
Liabilities
19078000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
145618000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124220000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21415000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40493000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
127000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-25882000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-567000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-82818000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.97
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13111067
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
245000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
148000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
49000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
899000
CY2018Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2017Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49563000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32670000
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0073
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0033
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0396
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2039
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32119227
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25354651
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25354651
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32119227
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
345000
CY2016 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
520000
CY2018 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
clsd:LicenseAndCollaborationMember
CY2017 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
clsd:LicenseAndCollaborationMember
CY2016 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
clsd:LicenseAndCollaborationMember
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
68291000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49053000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19455000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14684000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9700000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6263000
CY2018 us-gaap Operating Expenses
OperatingExpenses
82975000
CY2017 us-gaap Operating Expenses
OperatingExpenses
58753000
CY2016 us-gaap Operating Expenses
OperatingExpenses
25718000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-82945000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-58408000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-25198000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-36659000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2016 clsd Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
410000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51377000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
48198000
CY2016 clsd Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
308000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1314000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
71659000
CY2017 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
5057000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000
CY2018 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
159000
CY2018 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
79564000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
50000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
465000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4785000
CY2018 us-gaap Profit Loss
ProfitLoss
-82818000
CY2017 us-gaap Profit Loss
ProfitLoss
-58975000
CY2018 us-gaap Depreciation
Depreciation
189000
CY2017 us-gaap Depreciation
Depreciation
182000
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
211000
CY2018 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
112000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
156000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2597000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
748000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
31000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
505000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
833000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-21000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-882000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-314000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4715000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1424000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-20000
CY2016 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-520000
CY2018 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-76000
CY2017 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
97000
CY2016 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-9000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51083000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22709000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
80142000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
48116000
CY2016 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
54485000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
76470000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
68543000
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5708000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
360000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
306000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3760000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20121000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-49140000
CY2017 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
5057000
CY2016 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
33456000
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
51376000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
465000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
239000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
50000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
66000
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
10000000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7857000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8300000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6330000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81779000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5362000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86390000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1181000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25600000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14541000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9584000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35184000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20643000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8403000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
751000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
653000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
250000
CY2017 clsd Noncash Tenant Improvements Paid By Landlord
NoncashTenantImprovementsPaidByLandlord
637000
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
48198000
CY2016 clsd Reclassification Of Deferred Initial Public Offering Costs
ReclassificationOfDeferredInitialPublicOfferingCosts
1597000
CY2016 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
884000
CY2016 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
507000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting periods. Significant items subject to such estimates and assumptions include the accounting for useful lives to calculate depreciation and amortization, clinical trial accruals, share-based compensation expense and income tax valuation allowance. Actual results could differ from these estimates.</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk Arising From Cash Deposits in Excess of Insured Limits</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains its cash in bank deposits that at times may exceed federally insured limits. The Company has not experienced any loss in such accounts. The Company believes it is not exposed to any significant risks with respect to its cash balances.</p>
CY2018 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2011-05-26
CY2016Q4 clsd Public Offering Closing Date
PublicOfferingClosingDate
2016-12-14
CY2018Q1 clsd Stock Issued During Period Shares Follow On Offering
StockIssuedDuringPeriodSharesFollowOnOffering
6538462
CY2018Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
13.00
CY2018Q1 clsd Net Proceeds After Deducting Underwriting Discounts And Commissions And Estimated Offering Expenses
NetProceedsAfterDeductingUnderwritingDiscountsAndCommissionsAndEstimatedOfferingExpenses
79600000
CY2018Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
40900000
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 clsd Short Term Investments Maturity Period Range Start
ShortTermInvestmentsMaturityPeriodRangeStart
P90D
CY2018 clsd Short Term Investments Maturity Period Range End
ShortTermInvestmentsMaturityPeriodRangeEnd
P365D
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34824000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
360000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1199000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1132000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
409000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
247000
CY2018Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1263000
CY2017Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
3360000
CY2018Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1088000
CY2017Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
920000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
63000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
62000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
103000
CY2017Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
113000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
76000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
58000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
330000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
203000
CY2018 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
791000
CY2017 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
653000
CY2018 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
154000
CY2017 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
211000
CY2018 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
112000
CY2017 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
212000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
556000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3333000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3333000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2778000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
10000000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInNextTwelveMonths
845000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearTwo
651000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearThree
366000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearFour
638000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearFour
3416000
CY2018Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPayment
12500000
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41152000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27999000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391000
CY2017Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
248000
CY2016Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
358000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
1000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
38000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
69000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
387000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0198
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0397
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0162
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1242
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3743
CY2018 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.0351
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
101000
CY2018Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
125000
CY2017Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
18000
CY2016Q4 clsd Deferred Tax Assets Depreciation Differences
DeferredTaxAssetsDepreciationDifferences
13000
CY2016Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25446000
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0242
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0379
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0284
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.2513
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2017 clsd Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
14900000
CY2018 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Ownership changes, as defined by Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), may limit the amount of net operating losses that a company may utilize to offset future taxable income and taxes payable. Pursuant to Section 382 of the Code, an ownership change occurs when the stock ownership of 5% stockholders increases by more than 50% over a testing period of three years. It is possible that the Company has undergone an ownership change as defined by Section 382 of the Code or that the Company may undergo such a change in the future. Any such ownership change may limit the Company’s ability to utilize net operating losses.
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2900000
CY2018 clsd Non Cancelable Operating Leases Expiration Month And Year
NonCancelableOperatingLeasesExpirationMonthAndYear
2017-03
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
623000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
574000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
496000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
511000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
393000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
316000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
214000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
81000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
32836000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2018Q4 clsd Fair Value Assets Between Level1 Level2 And Level3 Transfers Amount
FairValueAssetsBetweenLevel1Level2AndLevel3TransfersAmount
0
CY2017Q4 clsd Fair Value Assets Between Level1 Level2 And Level3 Transfers Amount
FairValueAssetsBetweenLevel1Level2AndLevel3TransfersAmount
0
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
41238000
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38000000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3492892
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3105145
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2273371
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
16453000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
20904000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
23956000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
21662000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-16607000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-20701000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-23872000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-21638000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
10261000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
13768000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
18348000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
16376000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-10373000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-13773000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-18336000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-16493000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41

Files In Submission

Name View Source Status
0001564590-19-007887-index-headers.html Edgar Link pending
0001564590-19-007887-index.html Edgar Link pending
0001564590-19-007887.txt Edgar Link pending
0001564590-19-007887-xbrl.zip Edgar Link pending
clsd-10k_20181231.htm Edgar Link pending
clsd-20181231.xml Edgar Link completed
clsd-20181231.xsd Edgar Link pending
clsd-20181231_cal.xml Edgar Link unprocessable
clsd-20181231_def.xml Edgar Link unprocessable
clsd-20181231_lab.xml Edgar Link unprocessable
clsd-20181231_pre.xml Edgar Link unprocessable
clsd-ex1021_527.htm Edgar Link pending
clsd-ex231_6.htm Edgar Link pending
clsd-ex311_9.htm Edgar Link pending
clsd-ex312_8.htm Edgar Link pending
clsd-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gnallxlm0d5x000001.jpg Edgar Link pending
gnallxlm0d5x000002.jpg Edgar Link pending
gnallxlm0d5x000003.jpg Edgar Link pending
gnallxlm0d5x000004.jpg Edgar Link pending
gnallxlm0d5x000005.jpg Edgar Link pending
gnallxlm0d5x000006.jpg Edgar Link pending
gnallxlm0d5x000007.jpg Edgar Link pending
gnallxlm0d5x000008.jpg Edgar Link pending
gnallxlm0d5x000009.jpg Edgar Link pending
gnallxlm0d5x000010.jpg Edgar Link pending
gnallxlm0d5x000011.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending